An Overview of Pharmaceutical Excipients: Safe or Not Safe?

A medicine consists of 2 fundamental parts: the active pharmaceutical ingredient and the excipient. Most, if not all, medicines could not be made without the use of excipients. In the early times, the safety of excipients was overlooked and no specific safety tests were generally conducted. This fact has been changed over times and is currently being recognized that the excipient's toxicity is not negligible, because its direct interaction with the active pharmaceutical ingredient or between other excipients may occur, leading to a potential change in the relationship between effectiveness and toxicity. This review is intended to address the general status of the pharmaceutical excipients and to describe the safety assessment. As a summary, this review suggests the interest of simplifying the formulations as much as possible and the interest of reducing the number of excipients necessary to strictly meet the required functions. The risk/benefit ratio of an excipient should be always evaluated on the basis of not only its production and quality but also of its safety. Further research according to Good Manufacturing Practices, Guiding Principles in Toxicology Assessment, Good Laboratory Practices, and Good Distribution Practices requirements are needed and are fundamental for health safety, contributing to a comprehensive picture of this matter.

[1]  Hamed Hamishehkar,et al.  Evaluation of physicochemical properties and in vivo efficiency of atorvastatin calcium/ezetimibe solid dispersions. , 2016, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[2]  D. R. Karsa,et al.  Excipients and Delivery Systems for Pharmaceutical Formulations , 2002 .

[3]  Mohamed Ibrahim Noordin,et al.  Importance and globalization status of good manufacturing practice (GMP) requirements for pharmaceutical excipients. , 2015, Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society.

[4]  L. Block,et al.  Use of chitosan in compressed tablets of diclofenac sodium: inhibition of drug release in an acidic environment. , 1997, Pharmaceutical development and technology.

[5]  George Zografi,et al.  Water Vapor Sorption of Water-Soluble Substances: Studies of Crystalline Solids Below Their Critical Relative Humidities , 1987, Pharmaceutical Research.

[6]  Raymond C Rowe,et al.  Handbook of Pharmaceutical Excipients , 1994 .

[7]  R. Strickley Solubilizing Excipients in Oral and Injectable Formulations , 2004, Pharmaceutical Research.

[8]  B. S. Rao,et al.  Studies on enhancement of dissolution rate of etoposide , 2007 .

[9]  K. Kawazoe,et al.  Encapsulation in a rapid-release liposomal formulation enhances the anti-tumor efficacy of pemetrexed in a murine solid mesothelioma-xenograft model. , 2016, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[10]  Mayyas Al-Remawi,et al.  Chitin-silicon dioxide coprecipitate as a novel superdisintegrant. , 2008, Journal of pharmaceutical sciences.

[11]  Phipps,et al.  Application of isothermal microcalorimetry in solid state drug development. , 2000, Pharmaceutical science & technology today.

[12]  Crowley Excipients as stabilizers. , 1999, Pharmaceutical science & technology today.

[13]  Andrew Teasdale,et al.  ICH Q9 Quality Risk Management , 2017 .

[14]  P. C. Buxton,et al.  Degradation of glucose in the presence of electrolytes during heat sterilisation , 1994 .

[15]  Chen Kuang,et al.  Preparation and evaluation of taste masked oral suspension of arbidol hydrochloride , 2015 .

[16]  M A Zoglio,et al.  Pharmaceutical heterogeneous system. IV. A kinetic approach to the stability screening of solid dosage forms containing aspirin. , 1969, Journal of pharmaceutical sciences.

[17]  Patrizia Restani,et al.  The safety of pharmaceutical excipients. , 2003, Farmaco.

[18]  S. Bharate,et al.  Incompatibilities of Pharmaceutical Excipients with Active Pharmaceutical Ingredients: A Comprehensive Review , 2010 .

[19]  N. Murti Vemuri,et al.  Use of isothermal microcalorimetry in pharmaceutical preformulation studies , 2004 .

[20]  D. Carrier,et al.  A New Approach to Accelerated Drug-Excipient Compatibility Testing , 2003, Pharmaceutical development and technology.

[21]  Odon Planinšek,et al.  Determination of Solubility Parameters of Ibuprofen and Ibuprofen Lysinate , 2015, Molecules.

[22]  James Z. Xing,et al.  Excipient Interaction with Cetylpyridinium Chloride Activity in Tablet Based Lozenges , 2004, Pharmaceutical Research.

[23]  Mitsuru Uchiyama Regulatory Status of Excipients in Japan , 1999 .

[24]  B B Wray,et al.  Metabisulfite sensitivity: case report and literature review. , 1985, Annals of allergy.

[25]  Bruno C. Hancock,et al.  Differential scanning calorimetry: applications in drug development. , 1999, Pharmaceutical science & technology today.

[26]  G. L. Pramod,et al.  Global regulatory perspective of bulk pharmaceutical excipients , 2010 .

[27]  R. Johnson,et al.  Maillard reaction of lactose and fluoxetine hydrochloride, a secondary amine. , 1998, Journal of pharmaceutical sciences.

[28]  A. Bernkop‐Schnürch,et al.  Development and in vitro characterisation of an oral self-emulsifying delivery system for daptomycin. , 2016, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[29]  Roger A. Rajewski,et al.  Cyclodextrins: Their Future in Drug Formulation and Delivery , 1997, Pharmaceutical Research.

[30]  István Antal,et al.  Comparative evaluation of the effect of cyclodextrins and pH on aqueous solubility of apigenin. , 2016, Journal of pharmaceutical and biomedical analysis.

[31]  Robert Gurny,et al.  Bioadhesion: Possibilities and Future Trends , 1990 .

[32]  S. Chaudhari,et al.  Pharmaceutical Excipients: A review , 2012 .

[33]  M. Turner,et al.  Why are Excipients Important to Neonates? , 2015, Current pharmaceutical design.

[34]  S. Byrn,et al.  Chemical reactivity in solid-state pharmaceuticals: formulation implications. , 2001, Advanced drug delivery reviews.

[35]  Anna Tsantili-Kakoulidou,et al.  The potential of immobilized artificial membrane chromatography to predict human oral absorption. , 2016, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[36]  T. Mamatha,et al.  Drug-excipient interaction and its importance in dosage form development , 2011 .

[37]  Loyd V. Allen,et al.  Ansel'S Pharmaceutical Dosage Forms And Drug Delivery Systems , 2007 .

[38]  E Napke,et al.  Excipients and additives: hidden hazards in drug products and in product substitution. , 1984, Canadian Medical Association journal.

[39]  Jatinder Singh International conference on harmonization of technical requirements for registration of pharmaceuticals for human use , 2015, Journal of pharmacology & pharmacotherapeutics.

[40]  Flavia Laffleur,et al.  In vitro characterization of insulin containing thiomeric microparticles as nasal drug delivery system. , 2016, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[41]  Susan Thaul,et al.  How FDA Approves Drugs and Regulates Their Safety and Effectiveness [May 18, 2012] , 2012 .

[42]  K. Hartauer,et al.  Influence of Peroxide Impurities in Povidone and Crospovidone on the Stability of Raloxifene Hydrochloride in Tablets: Identification and Control of an Oxidative Degradation Product , 2000, Pharmaceutical development and technology.

[43]  Elias Mossialos,et al.  Regulating Pharmaceuticals In Europe: Striving For Efficiency, Equity And Quality , 2004 .

[44]  Sarfaraz Niazi,et al.  Bracketing and Matrixing Designs for Stability Testing of New Drug Substances and Products , 2016, Handbook of Pharmaceutical Manufacturing Formulations, Second Edition.

[45]  Rick Ng Drugs: From Discovery to Approval , 2004 .

[46]  Hans P Merkle,et al.  Drug delivery's quest for polymers: Where are the frontiers? , 2015, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[47]  Lu Xu,et al.  Control-release microcapsule of famotidine loaded biomimetic synthesized mesoporous silica nanoparticles: Controlled release effect and enhanced stomach adhesion in vitro. , 2016, Materials science & engineering. C, Materials for biological applications.

[48]  Danièle Giron,et al.  Contribution of thermal methods and related techniques to the rational development of pharmaceuticals—Part 2 , 1998 .

[49]  P Mura,et al.  Compatibility study between ibuproxam and pharmaceutical excipients using differential scanning calorimetry, hot-stage microscopy and scanning electron microscopy. , 1998, Journal of pharmaceutical and biomedical analysis.

[50]  A. Yehia,et al.  Chemometrics resolution and quantification power evaluation: Application on pharmaceutical quaternary mixture of Paracetamol, Guaifenesin, Phenylephrine and p-aminophenol. , 2016, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.

[51]  Rolando Perdomo-Morales,et al.  Soluble β-(1,3)-glucans enhance LPS-induced response in the monocyte activation test, but inhibit LPS-mediated febrile response in rabbits: Implications for pyrogenicity tests. , 2016, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[52]  L. Benet,et al.  Effect of inert tablet ingredients on drug absorption. I. Effect of polyethylene glycol 4000 on the intestinal absorption of four barbiturates. , 1966, Journal of pharmaceutical sciences.

[53]  Philippe Maincent,et al.  Bioavailability study of tolbutamide β-cyclodextrin inclusion compounds, solid dispersions and bulk powder , 1993 .

[54]  J. Sousa,et al.  Compatibility Studies Between Ibuprofen or Ketoprofen with Cellulose Ether Polymer Mixtures Using Thermal Analysis , 2005, Drug development and industrial pharmacy.

[55]  G Pifferi,et al.  Drug impurities: problems and regulations. , 1999, Bollettino chimico farmaceutico.

[56]  J. C. Callahan,et al.  Equilibrium Moisture Content of Pharmaceutical Excipients , 1982 .

[57]  Sarfaraz Niazi Oral Solutions and Suspensions , 2016 .

[58]  Véronique Nardello-Rataj,et al.  Pickering emulsions based on cyclodextrins: A smart solution for antifungal azole derivatives topical delivery. , 2016, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[59]  R. Torres-Palma,et al.  Comparative study of the effect of pharmaceutical additives on the elimination of antibiotic activity during the treatment of oxacillin in water by the photo-Fenton, TiO2-photocatalysis and electrochemical processes. , 2016, The Science of the total environment.

[60]  Javier Ellena,et al.  Mechanochemistry applied to reformulation and scale-up production of Ethionamide: Salt selection and solubility enhancement. , 2016, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[61]  Myra L. Weiner,et al.  Excipient Toxicity and Safety , 1999 .

[62]  Sudha Srivastava,et al.  Conformation and macromolecular interaction of ACE inhibitors enalapril and lisinopril by NMR , 1994 .

[63]  D H Gieringer,et al.  The safety and efficacy of new drug approval. , 1985, The Cato journal.

[64]  C. Goodman United States Pharmacopeial Convention , 1988 .

[65]  J L Lach,et al.  Dissolution-dialysis method of assessing in vitro drug availability of prednisolone tablets. , 1973, American journal of hospital pharmacy.

[66]  A Hertrampf,et al.  Advanced qualification of pharmaceutical excipient suppliers by multiple analytics and multivariate analysis combined. , 2015, International journal of pharmaceutics.

[67]  Arvind K. Bansal,et al.  Coprocessed excipients for solid dosage forms , 2004 .

[68]  D. B. Mitchell,et al.  A new approach to the safety assessment of pharmaceutical excipients. The Safety Committee of the International Pharmaceutical Excipients Council. , 1996, Regulatory toxicology and pharmacology : RTP.

[69]  W. Evering,et al.  An assessment of the ocular safety of inactive excipients following sub-tenon injection in rabbits. , 2008, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[70]  Maria Angela Vandelli,et al.  The grinding of the polymorphic forms of chloramphenicol stearic ester in the presence of colloidal silica , 1988 .

[71]  A. Weingart,et al.  Oxidativer Abbau von Linolsäuremethylester in Suspension anorganischer Hilfsstoffe. I: Autoxidation in Gegenwart von Kieselsäureprodukten und Aluminiumoxid , 1987 .

[72]  Pant,et al.  Drug-excipient interactions and their affect on absorption. , 2000, Pharmaceutical science & technology today.

[73]  A. Healy,et al.  Mitigating unwanted amorphisation: A screening method for the selection of suitable excipients. , 2016, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[74]  Stephen Edge,et al.  Adsorption of an Amine Drug onto Microcrystalline Cellulose and Silicified Microcrystalline Cellulose Samples , 2003, Drug development and industrial pharmacy.

[75]  Donald C. Monkhouse,et al.  Whither Compatibility Testing , 1989 .

[76]  Qibin Zhang,et al.  A perspective on the Maillard reaction and the analysis of protein glycation by mass spectrometry: probing the pathogenesis of chronic disease. , 2009, Journal of proteome research.

[77]  C. L. Winek HISTORY OF EXCIPIENT SAFETY AND TOXICITY , 2000 .

[78]  Sarfaraz Niazi,et al.  Impurities in New Drug Products , 2016, Handbook of Pharmaceutical Manufacturing Formulations.

[79]  Sanjay Garg,et al.  Compatibility studies between isosorbide mononitrate and selected excipients used in the development of extended release formulations. , 2004, Journal of pharmaceutical and biomedical analysis.

[80]  M. Son,et al.  Enteric-coated tablet of risedronate sodium in combination with phytic acid, a natural chelating agent, for improved oral bioavailability. , 2016, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[81]  K. Ikeda,et al.  Photo-enhanced modification of human skin elastin in actinic elastosis by N(epsilon)-(carboxymethyl)lysine, one of the glycoxidation products of the Maillard reaction. , 1997, The Journal of investigative dermatology.